Mass spectrometry (MS) based proteomics is a rapidly advancing field that has great promise for both understanding biological systems as well as advancing the identification and treatment of disease. Breakthroughs in science and medicine due to proteomics, however, are coupled with our ability to overcome significant challenges in the field. These challenges are multi-scalar, spanning the range from the statistics of molecules and molecular signals, to the phenomenological characterization of disease. The papers presented in this section are a representative snapshot of these challenges that span scale and scientific disciplines.
Revised: November 27, 2018 |
Published: December 31, 2006
Citation
Webb-Robertson B.M., W.R. Cannon, J.N. Adkins, and D.K. Gracio. 2006.The Challenge of Proteomic Data from Molecular Signals to Biological Networks and Disease. In Pacific Symposium On Biocomputing 2006, edited by R.B. Altman, et al, 212-218. Singapore:World Scientific.PNNL-SA-47364.doi:10.1142/9789812701626_0020